Evolutionary rate heterogeneity of Alu repeats upstream of the APOA5 gene: do they regulate APOA5 expression?

被引:0
|
作者
Edward A. Ruiz-Narváez
Hannia Campos
机构
[1] Harvard School of Public Health,Department of Nutrition, Room 202
[2] Harvard School of Public Health,Department of Epidemiology
来源
Journal of Human Genetics | 2008年 / 53卷
关键词
repeats; Apolipoproteins; Evolution; Substitution rate;
D O I
暂无
中图分类号
学科分类号
摘要
The APOA5 gene, located in the APOA1/C3/A4/A5 gene cluster, is a key regulator of triglyceride metabolism. ApoAV plasma concentration is much lower as compared to other apolipoproteins such as apoCIII and apoAI. This is due in part to the fact that the APOC3-enhancer, which up-regulates transcription of the APOA1, APOC3, and APOA4 genes, does not increase expression of the APOA5 gene. We postulated that intervening Alu repeats in the APOA5-APOA4 intergenic region gene might be blocking action of the APOC3-enhancer over the APOA5-promoter. To search for evidence of functional significance of the intervening Alu sequences, we estimated nucleotide substitution rates of 21 pairs of Alu elements in the APOA5-APOA4 intergenic region by comparing published sequences of human and chimpanzee. Also, we scanned the intergenic region for the presence of binding sites of the insulator protein CTCF. Seven out of the nine found CTCF binding sites were located in the first half of the intergenic region. Five out of those seven CTCF binding sites were placed inside Alu elements. Based on their substitution rates, we found two clearly defined groups of Alu sequences: a slow-evolving group (mean 0.98 ± 0.18) and a fast-evolving group (mean 2.74 ± 0.54). Alu repeats with lower substitution rate tended to be located up to 14-kb upstream of the APOA5 gene, to belong to the oldest J-family and to have an opposite orientation to the APOA5 gene. Some Alu sequences may have functional relevance on the regulation of the APOA5-gene expression.
引用
收藏
页码:247 / 253
页数:6
相关论文
共 50 条
  • [41] APOA5 SNPS AND METHYLATION JOINTLY CONTRIBUTE TO THE INDIVIDUAL PREDISPOSITION TO HYPERTRIGLYCERIDEMIA
    Oliva, I.
    Guardiola, M.
    Vallve, J. C.
    Ibarretxe, D.
    Plana, N.
    Monk, D.
    Masana, L.
    Ribalta, J.
    ATHEROSCLEROSIS, 2014, 235 (02) : E115 - E116
  • [42] The pathogenic mutations of APOA5 in Chinese patients with hyperlipidemic acute pancreatitis
    Liu, Yuxin
    Dai, Si
    Qin, Shuqi
    Zhou, Jing
    Wang, Zhendan
    Yin, Guojian
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [43] Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol
    Shirts, Brian H.
    Howard, Michael T.
    Hasstedt, Sandra J.
    Nanjee, M. Nazeem
    Knight, Stacey
    Carlquist, John F.
    Anderson, Jeffrey L.
    Hopkins, Paul N.
    Hunt, Steven C.
    ATHEROSCLEROSIS, 2012, 222 (01) : 167 - 174
  • [44] APOA5 Missense Mutations Associated with Chylomicronemia Sensitive to Fibrate Therapy
    Martinez, Alvaro
    Morineau, Gilles
    Dufernez, Fabienne
    Crie, Antoine
    Fruchart-Najib, Jamila
    Benlian, Pascale
    CIRCULATION, 2008, 118 (18) : S405 - S405
  • [45] Association of APOA1 and APOA5 polymorphisms and haplotypes with lipid parameters in a Brazilian elderly cohort
    Furuya, T. K.
    Chen, E. S.
    Ota, V. K.
    Mazzotti, D. R.
    Ramos, L. R.
    Cendoroglo, M. S.
    Araujo, L. Q.
    Burbano, R. R.
    Smith, M. A. C.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (03): : 3495 - 3499
  • [46] 高三酰甘油血症合并AMI患者APOA5基因甲基化对APOA5表达水平的影响
    余长风
    杜琼
    中国实验诊断学, 2014, (09) : 1435 - 1437
  • [47] Overweight modulates APOE and APOA5 alleles on the risk of severe hypertriglyceridemia
    Lee, Ming-Jen
    Chien, Kuo-Liong
    Chen, Ming-Fong
    Stephenson, Dennis A.
    Su, Ta-Chen
    CLINICA CHIMICA ACTA, 2013, 416 : 31 - 35
  • [48] Two novel APOA5 missense mutations in patients with severe hypertriglyceridemia
    Dorfmeister, B.
    Zeng, W-W.
    Schaap, F.
    Nierman, M.
    Kuivenhoven, J. A.
    Kastelein, J.
    Hubacek, J. A.
    Vrablik, M.
    Humphries, S. E.
    Talmud, P. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 138 - 138
  • [49] APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia
    Jian Wang
    Matthew R Ban
    Brooke A Kennedy
    Sonia Anand
    Salim Yusuf
    Murray W Huff
    Rebecca L Pollex
    Robert A Hegele
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 : 730 - 737
  • [50] The pathogenic mutations of APOA5 in Chinese patients with hyperlipidemic acute pancreatitis
    Yuxin Liu
    Si Dai
    Shuqi Qin
    Jing Zhou
    Zhendan Wang
    Guojian Yin
    Lipids in Health and Disease, 23